Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Mar;44(4):660-667.
doi: 10.1038/s41386-018-0191-9. Epub 2018 Aug 27.

Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies

Affiliations
Meta-Analysis

Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies

Felicia Kamp et al. Neuropsychopharmacology. 2019 Mar.

Abstract

Use of alcohol, cannabis and opioids is highly prevalent and is associated with global disease burden and high economic costs. The exact pathophysiology of abuse or addiction associated with these sedative substances is not completely understood, but previous research implicates the important role of the striatal dopamine system in the addiction process. Multiple studies investigated changes in the striatal dopamine systems of users of sedative substances, but currently these results are very heterogeneous. Therefore, we conducted a meta-analysis of in vivo neuroimaging studies investigating dopaminergic alterations in the striatum of users of alcohol, opioids or cannabis. Analyses for each substance were conducted separately for the availability of D2/D3 dopamine receptors, dopamine transporters and dopamine synthesis capacity. In total, 723 substance users and 752 healthy controls were included. The results indicated a significant lower striatal D2/D3 receptor availability in alcohol users compared to controls (g = 0.46) but no difference in dopamine transporter availability or dopamine synthesis capacity. Our analysis indicated that changes of dopamine receptors and transporters are moderated by the duration of abstinence. Comparing opioid users with controls revealed a significant lower D2/D3 receptor availability (g = 1.17) and a significantly lower transporter availability (g = 1.55) in opioid users. For cannabis users, there was no significant difference in receptor availability compared to controls and too few studies provided information on dopamine transporter availability or synthesis capacity. Our analysis provides strong evidence for a central role of the striatal dopamine system in use of alcohol or opioids. Further studies are needed to clarify the impact of the dopamine system in cannabis users.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Barplot overview: changes of striatal dopamine in sedative drug users
Fig. 2
Fig. 2
Forest plot of meta-analysis of striatal dopaminergic function in alcohol users
Fig. 3
Fig. 3
Barplot overview: changes of substriatal dopamine in sedative drug users
Fig. 4
Fig. 4
Forest plot of meta-analysis of striatal dopaminergic function in opioid users
Fig. 5
Fig. 5
Forest plot of meta-analysis of striatal dopaminergic function in cannabis users

Similar articles

Cited by

References

    1. United Nations. Office on drugs and crime. World drug report 2017. Vienna: United Nations Publication; 2017.
    1. World Health Organization. Global status report on alcohol and health 2014. Geneva: World Health Organization; 2014.
    1. Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, et al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014;109:1320–33. doi: 10.1111/add.12551. - DOI - PubMed
    1. Ashok AH, Mizuno Y, Volkow ND, Howes OD. Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:511–9. doi: 10.1001/jamapsychiatry.2017.0135. - DOI - PMC - PubMed
    1. Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does and doesn’t do. Curr Opin Pharmacol. 2007;7:69–76. doi: 10.1016/j.coph.2007.02.001. - DOI - PubMed

Publication types

MeSH terms

Substances